Key Points
- Katalin Karikó, Hungarian-American biochemist and 2023 Nobel Prize winner in Physiology or Medicine, will receive her 23rd honorary doctorate from the University of Oxford at the Encaenia ceremony on 24 June 2026.
- Prior to spring 2026 US events include honorary doctorates from Drexel University on 14 May 2026 and Johns Hopkins University on 21 May 2026, where she will also deliver the commencement address.
- Karikó’s first honorary doctorate was from her alma mater, the University of Szeged, on 4 September 2021.
- She shares the 2026 Oxford Encaenia honours with six others: Prof Daron Acemoğlu, Carlos Acosta CBE, Prof Henry Louis Gates Jr, Billie Jean King, Prof Shuji Nakamura FREng, and Dame Emma Walmsley DBE.
- Since 2021, Karikó has received numerous honorary doctorates, recognising her pioneering mRNA research that enabled COVID-19 vaccines, developed with Drew Weissman.
- Ticket registration for Oxford’s Encaenia opens on 5 May 2026 for staff, students, alumni, and Congregation members.
- Johns Hopkins announced her role via a leaked video on 7 April 2026 and a Jeopardy!-style campaign.
Katalin Karikó, the Nobel Prize-winning mRNA pioneer, is set to receive her 23rd honorary doctorate from the University of Oxford at the Encaenia ceremony on 24 June 2026, capping a busy spring of US academic honours.
- Key Points
- Who is Receiving Oxford’s Honorary Doctorate in 2026?
- What Are the Details of Karikó’s US Spring 2026 Events?
- Why Has Karikó Earned So Many Honorary Doctorates?
- When and How Was the Oxford Announcement Made?
- Background of the Development
- Prediction: Impact on the Scientific and Academic Community
Oxford(Oxford Daily)May 04, 2026 – Professor Katalin Karikó will don her 23rd honorary doctoral robe at the University of Oxford this June, following honorary degrees from Drexel University on 14 May and Johns Hopkins University on 21 May 2026. The University of Szeged announced the news, highlighting her status as the first female Nobel laureate in her field and a trailblazer in mRNA technology vital to COVID-19 vaccines.
Who is Receiving Oxford’s Honorary Doctorate in 2026?
The University of Oxford confirmed seven recipients for honorary degrees at the 2026 Encaenia on 24 June, as posted on LinkedIn by Oxford University. Prof Katalin Karikó stands among Prof Daron Acemoğlu, Carlos Acosta CBE, Prof Henry Louis Gates Jr, Billie Jean King, Prof Shuji Nakamura FREng, and Dame Emma Walmsley DBE.
“Warm congratulations to Professor Katalin Karikó on being announced as an Honorary Degree recipient,”
The post stated, praising her “groundbreaking scientific achievements” and “extraordinary perseverance”.
As reported by the University of Szeged’s news service, Karikó’s Oxford honour follows US celebrations: “Meanwhile, on May 14, the scientist will receive an honorary degree at the medical faculty of Philadelphia’s Drexel University and address its graduation ceremony and another honorary degree from Johns Hopkins University on May 21”. This marks her 23rd such accolade since her first from Szeged in 2021.
What Are the Details of Karikó’s US Spring 2026 Events?
Johns Hopkins University leaked the news via video in April 07, 2026, announcing Karikó as the Class of 2026 commencement speaker on 21 May in Baltimore.
“Katalin Karikó will deliver the commencement speech for the Class of 2026.”
stated the JHU Newsletter. A YouTube video from JHU described her as the “visionary biochemist and 2023 Nobel Laureate,” noting her decades of mRNA work amid “scepticism, funding cuts, and professional hurdles” that paved the way for COVID-19 vaccines.
The University of Szeged detailed her Drexel event on 14 May, where she will receive an honorary degree from the medical faculty and speak. JHU Hub reported: “mRNA pioneer Katalin Karikó to give Johns Hopkins Commencement address,” crediting journalist Doug Donovan. Szeged called it her 20th honorary doctorate at JHU, part of a US commencement tradition since 2021.
Why Has Karikó Earned So Many Honorary Doctorates?
Karikó’s accolades stem from her mRNA research with Drew Weissman, earning the 2023 Nobel Prize for enabling COVID-19 vaccines. Xpatloop reported: “Hungarian Nobel Prize-winning researcher Katalin Kariko, the first female to receive the prize, will receive an honorary degree from the University of Oxford in June”. Her journey from obscurity to acclaim resonates globally, as JHU noted: “Her unwavering belief… laid the groundwork for… a new era of genetic medicine”.
Szeged emphasised:
“Since 2021, Katalin Karikó – widely recognised as a pioneer of mRNA research – has been a distinguished guest at commencement ceremonies across the United States”.
Oxford’s recognition underscores her “long-term commitment to science that truly serves society”.
When and How Was the Oxford Announcement Made?
Oxford University announced the 2026 recipients on 21 April 2026 via LinkedIn, stating: “CONFIRMED: Honorary degree recipients for 2026 announced… Ticket registration opens on May 05,” Szeged’s April 22, update called Oxford her 23rd honour, five years after her first. Xpatloop covered it on May 03, 2026, attributing details to Szeged.
Background of the Development
Katalin Karikó’s rise began in Hungary, earning her PhD from the University of Szeged before immigrating to the US. Her mRNA modifications, developed with Weissman at the University of Pennsylvania, overcame immune rejection barriers, enabling Pfizer-BioNTech and Moderna vaccines that saved millions during the pandemic. Despite early rejections, her persistence led to the 2023 Nobel, shared with Weissman.
Her honorary doctorates surged post-Nobel, from Szeged in 2021 to global institutions. By 2026, the tally reaches 23, reflecting academia’s embrace of her contributions to genetic medicine. These events, including Oxford’s Encaeniaa historic ceremony since 1670 position her as a symbol of scientific resilience.
Prediction: Impact on the Scientific and Academic Community
This development elevates Karikó’s profile among scientists, students, and researchers, inspiring perseverance in undervalued fields like mRNA technology. For the scientific and academic community, her Oxford honour—following US events—could spur funding and interest in vaccine innovation, potentially accelerating therapies for cancer and rare diseases. Universities may see increased applications to biomedical programmes, with her story motivating young women in STEM amid ongoing gender gaps. Her speeches at Drexel and Johns Hopkins could influence policy, emphasising collaborative research over commercial pressures, fostering a new generation committed to public-good science.
